StonvexLoading…
StonvexStonvexStonvexCore line items from ACN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Annual 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $36.79B | $18.74B | $69.67B | $17.73B |
Operating Income | $5.37B | $2.87B | $10.23B | $2.98B |
Net Income | $4.04B | $2.21B | $7.68B | $2.20B |
EPS (Diluted) | $6.47 | $3.54 | $12.15 | $3.49 |
Total Assets | $67.06B | $64.70B | $65.39B | $63.36B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.40B | $9.65B | $11.48B | $9.63B |
Free Cash Flow OCF − CapEx | $5.18B | $1.51B | $10.87B | $7.07B |
Shares Outstanding | 624.58M | 626.04M | 632.44M | 630.46M |